Xenon Pharmaceuticals (XENE) EBT Margin (2013 - 2025)
Xenon Pharmaceuticals' (XENE) quarterly EBT Margin came in at 861.6% in Q1 2025, up 96.99% on a QoQ basis from 28588.64% in Q3 2022.
Xenon Pharmaceuticals (XENE) EBT Margin (2013 - 2025) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 10 years of EBT Margin data on file, last reported at 861.6% in Q1 2025.
- On a quarterly basis, EBT Margin changed N/A year-over-year to 861.6% in Q1 2025; TTM through Dec 2025 was 4680.87%, a N/A change from a year earlier, with the FY2025 full-year figure at 4680.87%, changed N/A from the prior year.
- EBT Margin for Q1 2025 stood at 861.6%, up from 28588.64% in the prior quarter.
- Over the last five years, EBT Margin for XENE reached as high as 192.64% in Q3 2021 and fell as low as 28588.64% in Q3 2022.
- Historically, EBT Margin has averaged 4716.66% across 3 years, with a median of 766.36% in 2021.
- On a YoY basis, EBT Margin climbed as much as 13440 bps in 2022 and fell as far as 2839600 bps in 2022.
- Year by year, EBT Margin stood at 671.13% in 2021, then slumped by 4160 bps to 28588.64% in 2022, then jumped by 97 bps to 861.6% in 2025.
- Per Business Quant data, the three most recent EBT Margin figures were 861.6% in Q1 2025, 28588.64% in Q3 2022, and 5820.52% in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -861.60% |
| Sep 30, 2022 | -28,588.64% |
| Jun 30, 2022 | -5,820.52% |
| Mar 31, 2022 | -228.88% |
| Dec 31, 2021 | -671.13% |
| Sep 30, 2021 | -192.64% |
| Jun 30, 2021 | -1,006.58% |
| Mar 31, 2021 | -363.29% |
| Dec 31, 2020 | -239.55% |
| Sep 30, 2020 | -138.21% |
| Jun 30, 2020 | -1.60% |
| Mar 31, 2020 | -105.75% |
| Dec 31, 2019 | -342.81% |
| Sep 30, 2019 | -253.31% |
| Dec 31, 2017 | -50,718.75% |
| Sep 30, 2017 | -3,227.27% |
| Jun 30, 2017 | -51,893.33% |
| Mar 31, 2017 | -48,987.50% |
| Dec 31, 2016 | -2,595.21% |
| Sep 30, 2016 | -1,747.46% |